"Community Hospital, located off Macarthur Blvd, provides expert medical care to the residents of Northwest Indiana by investing in advanced technologies, innovative treatments and staff who are specially trained. The hospital utilizes teams of health professionals under multiple disciplines and shared governance among the nursing staff for increased collaboration and accountability in patient care. Our community health center covers everything from maternity services to emergency room services and more. All of these efforts have led to the achievement of numerous quality awards and accreditation's, recognizing Community Hospital's consistent excellence in patient outcomes and experiences."

During the past decade, The Community Hospital conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 53 clinical trials were completed, i.e. on average, 117.8% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 28 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Community Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 26 trials, followed by "Alliance for Clinical Trials in Oncology" with 13 trials sponsored, "SWOG Cancer Research Network" with 11 trials sponsored, "NSABP Foundation Inc" with 10 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Community Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 46 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 4 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "The Community Hospital" are "Breast Cancer" (14 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (5 trials) and "Fallopian Tube Mucinous Adenocarcinoma" (5 trials). Many other conditions were trialed in "The Community Hospital" in a lesser frequency.

Most popular intervention types in "The Community Hospital" are "Drug" (78 trials), "Other" (54 trials), "Biological" (29 trials), "Procedure" (18 trials) and "Device" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (28 trials), "Quality-of-Life Assessment" (26 trials), "Paclitaxel" (22 trials), "Carboplatin" (16 trials) and "Docetaxel" (12 trials). Other intervention names were less common.

The vast majority of trials in "The Community Hospital" are 63 trials for "All" genders, 36 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "The Community Hospital". undefined are not yet recruiting, 12 are recruiting, 37 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 45 completed trials in The Community Hospital, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in The Community Hospital, 0 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 76 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".